| Subcutaneous EPO with oral iron compared with oral iron for women with postpartum iron deficiency anaemia |
|
Patient or population: women with postpartum iron deficiency anaemia
Settings: obstetric care unit
Intervention: subcutaneous EPO with oral iron
Comparison: oral iron |
| Outcomes |
Illustrative comparative risks* (95% CI) |
Relative effect
(95% CI) |
No of Participants
(studies) |
Quality of the evidence
(GRADE) |
Comments |
| Assumed risk |
Corresponding risk |
|
Oral iron |
Subcutaneous EPO with oral iron |
| Maternal mortality |
See comment |
See comment |
Not estimable |
40
(0) |
See comment |
No maternal deaths were reported. |
|
Fatigue ‐ not reported |
See comment |
See comment |
Not estimable |
‐ |
See comment |
Not reported. |
|
Persistent anaemia symptoms ‐ not reported |
See comment |
See comment |
Not estimable |
‐ |
See comment |
Not reported. |
|
Thromboembolic events ‐ not reported |
See comment |
See comment |
Not estimable |
‐ |
See comment |
Not reported. |
| *The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio. |
| GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate. |
